1993
DOI: 10.1073/pnas.90.18.8434
|View full text |Cite
|
Sign up to set email alerts
|

Molecular distinction of three N-methyl-D-aspartate-receptor subtypes in situ and developmental receptor maturation demonstrated with the photoaffinity ligand 125I-labeled CGP 55802A.

Abstract: Activation of N-methyl-D-aspartate (NMD)A)receptors is essential for synaptic plasticity in the central nervous system and contributes to neuronal death under various pathological conditions. Although several subunits have been cloned, the structure of NMDA receptors in situ is unresolved. By using a photoreactive antagonist with nanomolar affnity to the NMDA-binding site, three types of receptors were differentiated by their pattern of photoaffinity-labeled METHODS The photoaffinity ligand 125I-labeled CGP 55… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

1994
1994
2002
2002

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(21 citation statements)
references
References 26 publications
0
21
0
Order By: Relevance
“…However, all of the structures enriched in the IRE-BP correspond to areas with abundant NMDA receptors (43). Because essentially all the IRE-BP localizations we have observed occur in areas of the brain substantially enriched in both NMDA receptors and NOS, physiologic regulation of the IRE-BP by these systems is feasible.…”
Section: Resultsmentioning
confidence: 86%
“…However, all of the structures enriched in the IRE-BP correspond to areas with abundant NMDA receptors (43). Because essentially all the IRE-BP localizations we have observed occur in areas of the brain substantially enriched in both NMDA receptors and NOS, physiologic regulation of the IRE-BP by these systems is feasible.…”
Section: Resultsmentioning
confidence: 86%
“…As with the antibody to NR 1, the widespread distribution of NR2A/B antibody is consistent overall with data from NMDA ligand binding studies, and has been discussed in detail for NR 1 antibody . As also noted in that article (see also Monaghan et al, 1993) and demonstrated by pharmacological/binding studies of subunit expression in cell cultures and oocytes (Buller et al, 1993;Marti et al, 1993;Raditsch et al, 1993;Wafford et al, 1993;Yamakura et al, 1993) presence of NMDA receptor complexes made up of NRl in combination with one or more NR2 subunits may account for many of the differences in ligand binding seen in different regions of the brain. Interestingly, higher dendritic staining with NR2A/B antibody, compared to higher cell body staining with our NRl antibody, corresponds with higher binding of NMDA-sensitive @H-glutamate in dendritic zones compared to white matter regions and cell body layers (Monaghan and Cotman, 1985) that is, suggesting a direct relationship between NR2 subunit and ligand-binding site distribution.…”
Section: Comparison To In Situ Hybridization and Ligand Binding Studiesmentioning
confidence: 89%
“…In addition, glycine also inhibited the binding in all areas. The effect was antagonized by the glycine antagonist, 7-CKA, in all regions, indicating that the possibility of negative allosteric modulation of [3H]-CGP 39653 binding, through the activation of the associated strychnine-insensitive glycine site of the NMDA receptor channel complex (Mugnaini et al, 1993) (Lynch et al, 1993;Marti et al, 1993;Laurie & Seeburg, 1994 (Buller et al, 1994) strictly paralleled that of the mRNA encoding for the NR2A subunit (Laurie & Seeburg, 1994 CPP and CGS 19755 which were more in accord with the low affinity site (Fagg et al, 1990;Grimwood et al, 1991 (Monaghan et al, 1988;Buller et al, 1994). It may be noteworthy that in our data, because of the different allosteric modulation, basal [3H]-CGP 39653 binding was already partially inhibited by the endogenous glycine to a greater extent in striatum with respect to the cerebral cortex and the thalamus.…”
Section: Discussionmentioning
confidence: 99%